swiss listing, page-2

First of all, this news is just a rehashing of old speculation. Months ago, they say "Oh, we might do this..." Now this round of stories just says, "Oh, just in case you forgot, we still might do this." There's no concrete news, other than the tone (ie, "we REALLY might do this").

Only one article that I saw actually said they would raise capital with the listing, and even then it was confusing and awkwardly worded:

"Mr Wolgen said it would aim to raise money with any Swiss listing, but also cautioned the group would play things carefully and did not want to be the first biotech to do an IPO.

"The company does not yet have a product on the market and had cash and financial assets of about $38 million as of the end of June.

"Clinuvel made a net loss of some $15 million in its 2008-2009 financial year.

"'The markets have opened up faster than we all anticipated and that shows that capital markets have a very short memory,' he said, adding that the group would also consider acquisitions and drug licensing deals to strengthen its business.

'The investor climate is much more favourable towards companies of our size,' Mr Wolgen added."

----------

My reaction: WOW. Nothing in here is upsetting to me, but that just opens so many new questions. First of all, the first sentence about raising capital is awkwardly worded. And how can a company that is already public have an IPO? I thought IPO referred to privately held companies going public. This would be an additional listing, not an initial listing. And then acquisitions and drug licensing. The way that is worded ("would also consider acquisitions... to strengthen its business") implies that Clinuvel would be doing the acquiring, as opposed to being acquired...

If Philipe Wolgen is currently entertaining ideas of acquiring other businesses, then he is far, far ahead of any of us. But they say fortune favors the bold.